Reversible	reversible	O	O
myocardial	myocardial	O	O
hypertrophy	hypertrophy	O	S_disease
induced	induced	O	O
by	by	O	O
tacrolimus	tacrolimus	S_chemical	O
in	in	O	O
a	a	O	O
pediatric	pediatric	O	O
heart	heart	O	O
transplant	transplant	O	O
recipient	recipient	O	O
:	:	O	O
case	case	O	O
report	report	O	O
.	.	O	O

Tacrolimus	tacrolimus	S_chemical	O
is	is	O	O
a	a	O	O
potent	potent	O	O
immunosuppressant	immunosuppressant	O	O
that	that	O	O
is	is	O	O
frequently	frequently	O	O
used	used	O	O
in	in	O	O
organ	organ	O	O
transplantation	transplantation	O	O
.	.	O	O

However	however	O	O
,	,	O	O
adverse	adverse	O	O
effects	effects	O	O
include	include	O	O
cardiac	cardiac	O	B_disease
toxicity	toxicity	O	S_disease
.	.	O	O

Herein	herein	O	O
we	we	O	O
describe	describe	O	O
transient	transient	O	O
myocardial	myocardial	O	O
hypertrophy	hypertrophy	O	S_disease
induced	induced	O	O
by	by	O	O
tacrolimus	tacrolimus	S_chemical	O
after	after	O	O
heart	heart	O	O
transplantation	transplantation	O	O
.	.	O	O

The	the	O	O
hypertrophy	hypertrophy	O	S_disease
caused	caused	O	O
no	no	O	O
clinical	clinical	O	O
symptoms	symptoms	O	O
but	but	O	O
was	was	O	O
noted	noted	O	O
because	because	O	O
of	of	O	O
elevation	elevation	O	O
of	of	O	O
plasma	plasma	O	O
brain	brain	O	O
natriuretic	natriuretic	O	O
peptide	peptide	O	O
concentration	concentration	O	O
and	and	O	O
confirmed	confirmed	O	O
at	at	O	O
echocardiography	echocardiography	O	O
.	.	O	O

Initially	initially	O	O
,	,	O	O
allograft	allograft	O	O
rejection	rejection	O	O
was	was	O	O
feared	feared	O	O
;	;	O	O
however	however	O	O
,	,	O	O
myocardial	myocardial	O	O
biopsy	biopsy	O	O
samples	samples	O	O
revealed	revealed	O	O
only	only	O	O
interstitial	interstitial	O	O
edema	edema	O	S_disease
and	and	O	O
mild	mild	O	O
myocardial	myocardial	O	O
hypertrophy	hypertrophy	O	S_disease
;	;	O	O
neither	neither	O	O
cellular	cellular	O	O
nor	nor	O	O
humoral	humoral	O	O
rejection	rejection	O	O
was	was	O	O
detected	detected	O	O
.	.	O	O

The	the	O	O
blood	blood	O	O
tacrolimus	tacrolimus	S_chemical	O
concentration	concentration	O	O
was	was	O	O
higher	higher	O	O
than	than	O	O
usual	usual	O	O
at	at	O	O
that	that	O	O
time	time	O	O
;	;	O	O
thus	thus	O	O
,	,	O	O
tacrolimus	tacrolimus	S_chemical	O
dosage	dosage	O	O
was	was	O	O
reduced	reduced	O	O
.	.	O	O

Myocardial	myocardial	O	O
hypertrophy	hypertrophy	O	S_disease
completely	completely	O	O
resolved	resolved	O	O
upon	upon	O	O
reducing	reducing	O	O
the	the	O	O
target	target	O	O
concentration	concentration	O	O
of	of	O	O
tacrolimus	tacrolimus	S_chemical	O
and	and	O	O
did	did	O	O
not	not	O	O
recur	recur	O	O
,	,	O	O
as	as	O	O
confirmed	confirmed	O	O
at	at	O	O
echocardiography	echocardiography	O	O
and	and	O	O
myocardial	myocardial	O	O
biopsy	biopsy	O	O
.	.	O	O

Thus	thus	O	O
,	,	O	O
we	we	O	O
conclude	conclude	O	O
that	that	O	O
tacrolimus	tacrolimus	S_chemical	O
induces	induces	O	O
reversible	reversible	O	O
myocardial	myocardial	O	O
hypertrophy	hypertrophy	O	S_disease
.	.	O	O

In	in	O	O
patients	patients	O	O
receiving	receiving	O	O
tacrolimus	tacrolimus	S_chemical	O
therapy	therapy	O	O
,	,	O	O
blood	blood	O	O
concentration	concentration	O	O
should	should	O	O
be	be	O	O
carefully	carefully	O	O
controlled	controlled	O	O
and	and	O	O
extreme	extreme	O	O
attention	attention	O	O
paid	paid	O	O
to	to	O	O
cardiac	cardiac	O	O
involvement	involvement	O	O
.	.	O	O

